Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally.
Intuitive Surgical stock last closed at $399.39, up 3.96% from the previous day, and has increased 29.65% in one year. It has overperformed other stocks in the Medical Instruments & Supplies industry by 0.35 percentage points. Intuitive Surgical stock is currently +56.72% from its 52-week low of $254.85, and -1.08% from its 52-week high of $403.76.
As of May 15, 2024, there are 354.71M ISRG shares outstanding. The market cap of ISRG is $141.67B. In the last 24 hours, 1.2M ISRG shares were traded.
You will need an online brokerage account in order to access the NASDAQ market and buy ISRG shares.
Based on our experience, eToro is the best stock brokerage. Here's why:
Get $10 towards your purchase of shares by creating an account with eToro now.
Open eToro AccountNow that you've chosen the best brokerage, the next step is to fill out some personal information so you can invest in ISRG today.
Now that you have finished signing up on the best stock app for beginners, you need to deposit funds:
Check out the video below to see the process of depositing funds into your brokerage account.
After you have identified the best place to buy Intuitive Surgical stock, it's crucial to research their stock prior to investing, so you can comprehend the risk and opportunity.
WallStreetZen was designed to help average investors do better fundamental analysis quickly.
You can see all of the due diligence checks on ISRG's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge ISRG's intrinsic value.
Using relative valuations ratios:
You can do additional valuation analysis on ISRG's stock here.
Out of 15 sell side analysts who monitor ISRG, the consensus analyst rating on Intuitive Surgical is a Strong Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
Joanne Wuensch, a top 7% analyst from Citigroup maintains ISRG with a strong buy rating and raises their ISRG price target from $428.00 to $462.00, on Apr 3, 2024.
Citigroup's Joanne Wuensch raised their price target on Intuitive Surgical (NASDAQ: ISRG) by 7.9% from $428 to $462 on 2024/04/03. The analyst maintained their Strong Buy rating on the stock.
The analyst said they updated price targets for names in their Medical Devices and Supplies portfolio as part of a Q1 2024 earnings preview.
Investors' expectations for the group remain "medium-to-high" for solid deliveries, encouraged by new products and pent-up demand, Wuensch reported.
Although the stock traded in line with the market YTD, the analyst noted that "the space doesn't really tell the current MedTech story."
Q1 earnings season, which is expected to be successful and to hurdle tough Y/Y comps, should set the tone for the remainder of the year, with new products remaining in focus, Wuensch continued.
The analyst named Boston Scientific, Irhythm Technologies, and Intuitive Surgical as their Medical Devices and Supplies top picks.
Anthony Petrone, a top 10% analyst from Mizuho maintains ISRG with a hold rating and raises their ISRG price target from $350.00 to $390.00, on Jan 25, 2024.
Matt Miksic, a bottom 5% analyst from Barclays maintains ISRG with a strong buy rating and raises their ISRG price target from $385.00 to $430.00, on Jan 25, 2024.
Jayson Bedford, a top 16% analyst from Raymond James maintains ISRG with a buy rating and raises their ISRG price target from $372.00 to $435.00, on Jan 25, 2024.
Shagun Singh, a bottom 44% analyst from RBC Capital maintains ISRG with a buy rating and raises their ISRG price target from $400.00 to $432.00, on Jan 24, 2024.
You can dive deeper into what analysts are forecasting on the Intuitive Surgical stock forecast page.
Last year, ISRG earnings were $1.99B. During the last 5 year, ISRG's earnings have gone up by 11% per year. This was slower than the Medical Instruments & Supplies industry average of 13.26%.
Last year, ISRG revenue was $7.32B. In the past five year, ISRG's revenue has grown by 13.71% per year. This was faster than the Medical Instruments & Supplies industry average of 10.07%.
Find out more about ISRG's earnings and revenue performance here.
In the past year, insiders at ISRG have bought more shares than they have sold.
Mark Brosius, SVP Chief Mfg and Supply Cha of ISRG, was the latest ISRG insider to sell. They sold $67,763.50 worth of ISRG stock on May 15, 2024.
Learn more about who owns ISRG shares here.
No, Intuitive Surgical doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
There are two main order types:
Press the Open button and eToro will place your order.
If you require more assistance investing in stocks on eToro, watch the how to video below:
Now that you own some ISRG stock, you'll want to stay up-to-date on your investment.
Add ISRG to a watchlist to get notified of the latest news about your ISRG stock.
To reiterate, here are the 6 steps you need to take to buy Intuitive Surgical stock right now:
If you require a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get the latest scoop on your new investment in Intuitive Surgical, hit the button below to create your watchlist.